Funding Disclosure & Independence
Read our funding and conflict-of-interest disclosure, including publishing commitments and operational details that remain unconfirmed.
This page sets out our publishing commitments. External medical review is a separate process; check the review status on each article.
The publication’s operating model
Inside Peptides presents itself as an independently published educational reference. Its stated operating model is private self-funding by its founding editors, with no peptide sales, vendor advertising, paid product placements, or affiliate commissions.
This disclosure explains that model and the safeguards expected of it. It is not an audited financial statement. The site does not currently publish a detailed budget, independently audited accounts, or a named financial backer register.
What readers can expect
Editorial inclusion, placement, comparisons, and evidence descriptions must not be available for purchase. We do not provide shopping links for peptides or earn a commission when a reader purchases a product discussed in an article.
The publication’s stated policy excludes sponsorship from peptide vendors, clinics, compounding pharmacies, and pharmaceutical or biotechnology manufacturers. If that policy or operating model changes, the disclosure must be updated before the new relationship is represented on the site.
What operational funding supports
A reference website has costs for hosting, technical maintenance, design, literature access, research, writing, and editorial checking. Funding those activities does not establish that every article has received external medical review.
Medical review status must be disclosed separately on the article. Readers should not infer an independent clinical panel, charitable status, accreditation, or institutional backing from the existence of this funding policy.
Editorial decisions and financial influence
Funders and contributors should have no right to purchase a conclusion, suppress an unfavorable finding, select only favorable studies, or delay a scientifically necessary correction. Article priorities should follow reader needs and evidence relevance.
Potential financial interests should be evaluated before an assignment. A contributor’s relevant consulting, employment, investment, intellectual property, or other relationships may require disclosure or reassignment even if the website itself accepts no advertising.
Research funding versus publication funding
The organization that funds a cited clinical trial is separate from the organization that funds this website. A study sponsored by a manufacturer can be relevant evidence and should be assessed critically with its disclosures and methods visible.
Citing a study does not imply that its sponsor supports Inside Peptides. Likewise, linking to a university, journal, regulator, or registry does not imply endorsement or partnership.
Future donations, grants, or partnerships
Any future funding arrangement should be assessed for its compatibility with editorial independence before acceptance. A disclosure should identify the source of support, its nature, relevant restrictions, and any relationship to the subjects covered.
The publication should explain whether support is unrestricted or tied to a project, who retains editorial control, and whether readers will see any sponsored material. A funding change must not be hidden behind an unchanged independence statement.
Questions about this disclosure
Readers may request clarification through the contact page, including questions about an apparent commercial relationship or a contributor disclosure. Please provide the relevant page or relationship so the concern can be assessed.
Where a financial statement or independence claim is inaccurate, it should be corrected under the Corrections Policy. This disclosure should be revisited when the operating model changes, rather than merely receiving a new date without substantive review.